Brain metastasis in colorectal cancer presenting as refractory hypertension
Background: Brain metastasis (BM) from colorectal cancer (CRC) is rare with the incidence ranging from 0.6% to 3.2%. There is also an increased incidence of BM with rectal primaries and is consistent with this patient’s presentation. Overall, there is scarce literature on the symptoms of patients wh...
Main Authors: | Syed Moin Hassan, Ateeq Mubarik, Salman Muddassir, Furqan Haq |
---|---|
Format: | Article |
Language: | English |
Published: |
Greater Baltimore Medical Center
2018-07-01
|
Series: | Journal of Community Hospital Internal Medicine Perspectives |
Subjects: | |
Online Access: | http://dx.doi.org/10.1080/20009666.2018.1490138 |
Similar Items
-
Volumetric reduction of brain metastases after stereotactic radiotherapy: Prognostic factors and effect on local control
by: Naoyuki Kanayama, et al.
Published: (2022-12-01) -
Stereotactic radiosurgery versus whole-brain radiotherapy after resection of solitary brain metastasis: A systematic review and meta-analysis
by: Nikolaos Vlachos, et al.
Published: (2023-04-01) -
Single-fraction SRS and multiple-fraction SRT for brain metastases from colorectal cancer
by: Yong Li, et al.
Published: (2022-12-01) -
Advances in Treatment of Brain Metastasis from Lung Cancer
by: SUN Junzhao, et al.
Published: (2022-06-01) -
Efficacy and Safety of a Second Course of Stereotactic Radiation Therapy for Locally Recurrent Brain Metastases: A Systematic Review
by: François Lucia, et al.
Published: (2021-09-01)